Abstract |
112 patients admitted to hospital with a diagnosis of erysipelas, were randomized to 8 days treatment with prednisolone or placebo in addition to antibiotics. 108 patients received the study drugs and were evaluated for time to cure, which was the primary end-point. The median healing time was significantly shorter in the prednisolone group, 5 days, vs 6 days in the placebo group (p < 0.01). The 90th percentile healing time was 10.0 days in the prednisolone group vs 14.6 days in the control group. The prednisolone-treated patients had a median length of hospital stay (secondary end-point) of 5 days vs 6 for the placebo-treated (p < 0.01). The median treatment time with intravenous antibiotics (secondary end-point) was 4 days in the placebo group, which was 1 day longer than in the prednisolone group (p < 0.05). 13 patients, 7 of whom received placebo, relapsed during the observation period of 3 weeks. The frequency of side effects attributable to the study drug was not higher in the prednisolone group.
|
Authors | P I Bergkvist, K Sjöbeck |
Journal | Scandinavian journal of infectious diseases
(Scand J Infect Dis)
Vol. 29
Issue 4
Pg. 377-82
( 1997)
ISSN: 0036-5548 [Print] England |
PMID | 9360253
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Penicillins
- Prednisolone
|
Topics |
- Anti-Inflammatory Agents
(administration & dosage, adverse effects, therapeutic use)
- Bacteremia
(diagnosis)
- Double-Blind Method
- Drug Therapy, Combination
- Erysipelas
(drug therapy)
- Female
- Hospitalization
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Penicillins
(administration & dosage, therapeutic use)
- Prednisolone
(administration & dosage, adverse effects, therapeutic use)
- Recurrence
- Staphylococcal Infections
(blood, diagnosis)
- Staphylococcus aureus
(growth & development)
- Streptococcal Infections
(blood, diagnosis)
- Streptococcus
(growth & development)
|